These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 7018736
21. Heparin influences human platelet behavior in cardiac surgery with or without cardiopulmonary bypass. Laga S, Bollen H, Arnout J, Hoylaerts M, Meyns B. Artif Organs; 2005 Jul; 29(7):541-6. PubMed ID: 15982282 [Abstract] [Full Text] [Related]
22. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Velik-Salchner C, Maier S, Innerhofer P, Kolbitsch C, Streif W, Mittermayr M, Praxmarer M, Fries D. Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196 [Abstract] [Full Text] [Related]
23. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue. Huddleston CB, Hammon JW, Wareing TH, Lupinetti FM, Clanton JA, Collins JC, Bender HW. J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591 [Abstract] [Full Text] [Related]
24. Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass. Carteaux JP, Roux S, Kuhn H, Tschopp T, Colombo V, Hadváry P. J Thorac Cardiovasc Surg; 1993 Nov; 106(5):834-41. PubMed ID: 8231205 [Abstract] [Full Text] [Related]
25. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment. Nakajima T, Osawa S, Ogawa M, Sasaki T, Izumoto H, Yagi Y, Kawazoe K. ASAIO J; 1996 Nov; 42(4):301-5. PubMed ID: 8828788 [Abstract] [Full Text] [Related]
26. Platelet damage by protamine and the protective effect of prostacyclin: an experimental study in dogs. Velders AJ, Wildevuur CR. Ann Thorac Surg; 1986 Aug; 42(2):168-71. PubMed ID: 3527093 [Abstract] [Full Text] [Related]
27. Temporary inhibition of platelet function with iloprost (ZK36374) preserves canine platelets during extracorporeal membrane oxygenation. Cottrell ED, Kappa JR, Stenach N, Fisher CA, Tuszynski GP, Switalska HI, Addonizio VP. J Thorac Cardiovasc Surg; 1988 Oct; 96(4):535-41. PubMed ID: 2459560 [Abstract] [Full Text] [Related]
28. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Kozek-Langenecker SA, Spiss CK, Michalek-Sauberer A, Felfernig M, Zimpfer M. Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998 [Abstract] [Full Text] [Related]
29. Somatosensory evoked potentials and cerebral metabolism during cardiopulmonary bypass with special reference to hypotension induced by prostacyclin infusion. Arén C, Badr G, Feddersen K, Rådegran K. J Thorac Cardiovasc Surg; 1985 Jul; 90(1):73-9. PubMed ID: 3925243 [Abstract] [Full Text] [Related]
30. The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass. Malpass TW, Amory DW, Harker LA, Ivey TD, Williams DB. J Thorac Cardiovasc Surg; 1984 Apr; 87(4):550-5. PubMed ID: 6231433 [Abstract] [Full Text] [Related]
31. Inhibition of platelet deposition on polytetrafluoroethylene grafts by antiplatelet agents. Kon ND, Hansen KJ, Martin MB, Meredith JW, Meredith JH, Cordell AR. Surgery; 1984 Nov; 96(5):870-3. PubMed ID: 6387989 [Abstract] [Full Text] [Related]
32. [Effect of a high single subcutaneous dose of unfractionated heparin on platelet function in dogs]. Mischke R, Nimmerfall K. Berl Munch Tierarztl Wochenschr; 2000 Feb; 113(2):60-4. PubMed ID: 10726363 [Abstract] [Full Text] [Related]
33. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog. Imai S, Matsubara I. Artery; 1980 Feb; 8(1):63-72. PubMed ID: 7000043 [Abstract] [Full Text] [Related]
34. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization. DiSesa VJ, Huval W, Lelcuk S, Jonas R, Maddi R, Lee-Son S, Shemin RJ, Collins JJ, Hechtman HB, Cohn LH. Ann Thorac Surg; 1984 Nov; 38(5):514-9. PubMed ID: 6388516 [Abstract] [Full Text] [Related]
35. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study. Chung A, Wildhirt SM, Wang S, Koshal A, Radomski MW. J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644 [Abstract] [Full Text] [Related]
36. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T. Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358 [Abstract] [Full Text] [Related]
37. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass. Tao W, Deyo DJ, Brunston RL, Vertrees RA, Grochoske TL, Zwischenberger JB. ASAIO J; 1997 Apr; 43(5):M825-30. PubMed ID: 9360162 [Abstract] [Full Text] [Related]
38. Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators. Peterson KA, Dewanjee MK, Kaye MP. J Thorac Cardiovasc Surg; 1982 Jul; 84(1):39-43. PubMed ID: 7087539 [Abstract] [Full Text] [Related]
39. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. Gunaydin S, Farsak B, McCusker K, Vijay V, Sari T, Onur MA, Gurpinar A, Zorlutuna Y. J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380 [Abstract] [Full Text] [Related]
40. Platelet function, coagulation tests, and cardiopulmonary bypass: lack of correlation between pre-operative and intra-operative whole blood lumiaggregometry and peri-operative blood loss in patients receiving autologous platelet-rich plasma. Irani MS, Izzat NN, Jones JW. Blood Coagul Fibrinolysis; 1995 Jul; 6(5):428-32. PubMed ID: 8589209 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]